NANOCI—Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons by Senn, Pascal et al.
Otology & Neurotology
38:e224–e231 Copyright  2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.NANOCI—Nanotechnology Based Cochlear Implant With
Gapless Interface to Auditory Neuronsy§§Pascal Senn, yMarta Roccio, yStefan Hahnewald, zClaudia Frick, zMonika Kwiatkowska,
zMasaaki Ishikawa, zPeter Bako, §Hao Li, §Fredrik Edin, §Wei Liu, §Helge Rask-Andersen,
jjIlmari Pyykko¨, jjJing Zou, jjMarika Mannerstro¨m, {Herbert Keppner, {Alexandra Homsy,
{Edith Laux, {Miguel Llera, #Jean-Paul Lellouche, #Stella Ostrovsky, #Ehud Banin,
#Aharon Gedanken, #Nina Perkas, Ute Wank, Karl-Heinz Wiesmu¨ller, yyPavel Mistrı´k,
yyHeval Benav, yyCarolyn Garnham, yyClaude Jolly, zzFilippo Gander, zzPeter Ulrich,
zMarcus Mu¨ller, and zHubert Lo¨wenheim
University Department of ORL, Head & Neck Surgery, Inselspital; yDepartment of Clinical Research, University of Bern, Bern,
Switzerland; zDepartment of Otorhinolaryngology–Head &Neck Surgery, University of Tu¨bingen, Tu¨bingen, Germany; §Department
of Surgical Sciences, Section of ORL, Uppsala University, Uppsala, Sweden; jjHearing and Balance Research Unit, Department of
Otorhinolaryngology and The Finnish Centre for Alternative Methods, University of Tampere, Tampere, Finland; {Haute Ecole Arc
Inge´nierie, HES-SO - University of Applied Sciences Western Switzerland, La Chaux-de-Fonds; #Department of Chemistry, The
Center for Advanced Materials and Nanotechnology and The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan
University, Ramat Gan, Israel; EMC Microcollections GmbH, Tu¨bingen, Germany; yyMED-EL GmbH, Worldwide Headquarters,
Innsbruck, Austria; zzSCIPROM Sa`rl, Rue du Centre 70, St-Sulpice; and §§Department of Clinical Neurosciences,
Service of ORL and HNS, HUG, University Hospital of Geneva, Geneva, SwitzerlandCopyright © 2017
Address correspondenc
Department of Clinical N
Universitaires de Gene`ve
Geneva, Switzerland; E-m
M.M. and H.L. have e
Disclosure: The NANO
the European Union unde
frame work programme.
The authors disclose n
This is an open acces
Creative Commons Att
License 4.0 (CCBY-NC-
and share the work provi
changed in any way or use
journal.
DOI: 10.1097/MAO.0I) restore functional hearing in the
nts. Despite the tremendous success of
electrode array. This ambitious goal wa
neurotrophin-induced attraction of neurCochlear implants (C
majority of deaf patie
these devices, some limitations remain. The bottleneck for
optimal electrical stimulation with CI is caused by the
anatomical gap between the electrode array and the auditory
neurons in the inner ear. As a consequence, current devices
are limited through 1) low frequency resolution, hence sub-
optimal sound quality and 2), large stimulation currents,
hence high energy consumption (responsible for significant
battery costs and for impeding the development of fully
implantable systems). A recently completed, multinational
and interdisciplinary project called NANOCI aimed at over-
coming current limitations by creating a gapless interface
between auditory nerve fibers and the cochlear implant Otology & Neurotology, Inc. Unauthorized
e and reprint requests to Pascal Senn, M.D.,
eurosciences, Service ORL & CCF, Hoˆpitaux
(HUG), Rue Gabrielle Perret-Gentil 4, 1211
ail: pascal.senn@hcuge.ch
qual contribution to the article.
CI-project (www.nanoci.org) was funded by
r the grant agreement no. 281056 in the 7th
o conflicts of interest.
s article distributed under the terms of the
ribution-Non Commercial-No Derivatives
ND), where it is permissible to download
ded it is properly cited. The work cannot be
d commercially without permission from the
000000000001439
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ites through an intra-
cochlear gel-nanomatrix onto a modified nanoCI electrode
array located in the scala tympani of deafened guinea pigs.
Functionally, the gapless interface led to lower stimulation
thresholds and a larger dynamic range in vivo, and to reduced
stimulation energy requirement (up to fivefold) in an in vitro
model using auditory neurons cultured on multi-electrode
arrays. In conclusion, the NANOCI project yielded proof of
concept that a gapless interface between auditory neurons and
cochlear implant electrode arrays is feasible. These findings
may be of relevance for the development of future CI systems
with better sound quality and performance and lower energy
consumption. The present overview/review paper summarizes
the NANOCI project history and highlights achievements
of the individual work packages. Key Words: Auditory
nerve regeneration—BDNF—Cochlear implant—Gapless
interface—Guinea pig—Hearing loss—Hydrogel—Multi-
electrode array—Neuron–electrode interface.
Otol Neurotol 38:e224–e231, 2017. reproduction of this (CI) have becomCochlear implants e the gold standard
treatment for acquired and congenital deafness, allowing
the restoration of functional hearing in the majority of
recipients. As of today over 300,000 devices are in use.
Despite the tremendous success of current systems, there is
a substantial variability of performance across CI-users. In
some cases, sound quality is poor for music and tonal
languages, and users may struggle in noisy environments.article is prohibited.
FIG. 1. Schematic concept of the NANOCI project. Overview (A) and mid-modiolar cross-section through the cochlea with a CI electrode
array inserted into the scala tympani (pink, B) at distance from the auditory neuron (green, B–D). By providing structural support, guidance,
and attraction cues from an injected, functionalized nanomatrix (blue shaded fill, B–D) and from the modified electrode array surface (white
coating of pink electrode array, C and D), a guided growth of the neurite onto the electrode surface is induced where a gapless nerve-CI
interface is formed. CI indicates cochlear implants.
NANOCI e225The major bottleneck for optimized stimulation is the
anatomical gap between the implanted electrode array
and the stimulated regions of the auditory nerve. As a
consequence of the gap and the associated current spread
during a stimulus pulse, thousands of auditory neurons are
stimulated from devices featuring only between 12 and 22
electrodes (depending on the manufacturer). Whereas
more than eight independent channels are needed in
challenging listening situations (1), CI users typically
perform as if they have only about eight channels of
information (2). The main reason for this is spread of
excitation from the electrodes and interference across
channels. Any attempt to increase channel numbers is
limited by this significant ‘‘cross talk’’ of electrodes or
overlapping electrical fields. Hence, the resolution and
specificity of neuronal stimulation is low, which is the
main reason for suboptimal sound quality and variability
of speech and music perception. Additionally, the high
amplitudes contribute to a high energy consumption
associated with significant maintenance costs for batteries.
Moreover, high energy consumption challenges the devel-
opment of fully implantable systems, which would have
several advantages such as increased usability for small
children, invisibility, hearing while sleeping and better
acceptance by patients.
It is generally acknowledged that eliminating the
gap between neurons and the electrode array, and
increasing the number of active channels, should
greatly improve the effectiveness of auditory nerve
stimulation (3).Copyright © 2017 Otology & Neurotology, Inc. UnautThe NANOCI project, therefore, was conceived with
the aim to create a gapless man:machine interface in the
cochlea by attracting the peripheral processes of the
auditory nerve towards the electrode array (Fig. 1). Such
a gapless interface could open the door for a higher
frequency resolution of the CI system, because smaller
groups of auditory neurons could be stimulated from a
higher number of separate electrodes, coming closer to
the situation in the ‘‘normal’’ human inner ear, where
around 3,500 inner hair cells stimulate around 30,000
auditory neurons. In acoustic simulation studies for
normal hearing subjects, a higher frequency resolution
is associated with improved speech and music percep-
tion. In addition to this, the gapless interface has a high
chance of cutting down energy consumption.
Supportive evidence for the feasibility of the NANOCI
aim to recruit spiral ganglion neuron (SGN) processes to
the CI can be found in the literature. Different neuro-
trophins have been reported to have prosurvival and
guidance effects on SGNs. First, during embryonic devel-
opment, auditory hair cells express the neurotrophin
proteins brain-derived neurotrophic factor (BDNF) and
neurotrophin-3, which direct growth of radial fiber bun-
dles from the centrally localized spiral ganglion into the
organ of Corti (4). Directed growth of nerve fibers can
also be induced experimentally after infection of sup-
porting cells with adenoviral vectors encoding for BDNF
leading to its production in adult deafened guinea pigs
(5). Similarly, BDNF in combination with fibroblast
growth factor was capable of promoting survival andhorized reproduction of this article is prohibited.
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TABLE 1. List of NANOCI consortium partner institutions with key competences
Role Affiliation Key Competences
Coordinator University of Bern, Switzerland Inner ear regeneration, human and murine bioassays, in vitro
electrophysiology (multi-electrode arrays)
Partner 1 University of Tu¨bingen, Germany In vivo electrophysiology, histology, murine bioassays
Partner 2 University of Uppsala, Sweden Human bioassays, time-lapse video
Partner 3 University of Tampere, Finnland Nanotoxicity assays in vitro, drug release studies, CB-CT and MRI
imaging
Partner 4 University of applied sciences,
HES-SO, La Chaux-de-Fonds,
Switzerland
Nanostructurization by solid on liquid deposition, irradiation;
drug-elution solutions, modeling of release
Partner 5 Bar-Ilan University, Ramat Gan, Israel Nanostructurization by sonochemistry, bacteria bioassays, production
of nanoparticles (e.g., carbon nanotubes)
Partner 6 EMC Microcollections, GmbH,
Tu¨bingen, Germany
Production of BDNF mimetics, purification and functionalization of
hydrogels
Partner 7 MEDEL, Innsbruck, Austria Production of animal- and human grade nanoCI prototypes with
surface functionalizations; modelling
Partner 8 Sciprom Sa`rl, St-Sulpice, Switzerland Project management, website design, organization of meetings
BDNF, brain-derived neurotrophic factor; CB-CT, conebeam computed tomography; MRI, magnetic resonance imaging.
e226 P. SENN ET AL.inducing re-sprouting of auditory neurons after exper-
imentally induced deafness in adult guinea pigs (6).
Moreover, these authors observed outgrowth of nerve
fibers up to the border of the scala tympani, where the
neurotrophins were released. The peripheral processes
of the auditory neurons did not, however, enter the
perilymph, possibly due to lack of structural support.
In addition, the neurotrophic effect of BDNF can be
enhanced if combined with electrical stimulation (7).
Finally, in a recent animal study it was shown that ectopic
nerve fibers observed in the cochlea in response to
chronic neurotrophin delivery were associated with lower
excitation thresholds and no increased spread of acti-
vation compared with deafened controls (8).
Importantly, specific neurotrophin receptors are
expressed in the human cochlear neural tissue also in
adulthood (9,10), making the treatment with exogenous
neurotrophins such as BDNF by local intracochlear
delivery system clinically highly relevant. Therefore,
based on the literature it seemed clear that neurotrophins
such as BDNF could be ideal candidates to induce and
re-direct neurite outgrowth towards a modified CI elec-
trode array acting as a source of delivery. Nevertheless,
the fluid filled gap between the neurons and the surface of
the CI electrode array would be likely to inhibit the
regrowth. To overcome this limitation, we thought that
a structural support should be offered, along with guid-
ance and growth cues to recruit neurons to the array
(Fig. 1).
For this challenging endeavor, expertize from different
backgrounds was merged in an international and multi-
centric consortium (Table 1—overview of consortium
partners and their key competences). The complex
research project was subdivided into several smaller units
(called work packages [WPs]) with defined goals and
milestones, which are discussed along with the results
obtained in more detail below. The main aim of the
present review article is to summarize the historicalCopyright © 2017 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. 38, No. 8, 2017background of the NANOCI project and to give an
overview of its achievements.
WP1—Nanomaterials and Bioactive Compounds for
Improving the Interface
The main objectives of this work package were: 1) to
develop a biocompatible and bio-functionalized, three-
dimensional scaffold, or nanomatrix, to promote neural
outgrowth of nerve fibers through the scala tympani onto
the surface of the CI electrode pad, 2) to develop bio-
mimetic analogues of BDNF, and 3) to introduce nano-
surface modifications of the electrode contacts to stably
lock neurons while improving the electrode conductive
properties.
In the first place, commercially available fiber forming
gel matrices were assessed. PuraMatrixTM was selected
as the best candidate as it fulfilled the basic requirements
of being injectable as solution, gelatinizing in response to
ionic changes (i.e., contact with the perilymph) without
swelling or mechanical stress to surrounding tissues.
In addition, it had been shown to promote neurite
growth (11).
Partner EMC microcollections GmbH (EMC) resynthe-
sized the published gel forming PuraMatrixTM peptide
sequence and additionally modified it with laminin-
derived sequences for neuron adhesion. Additionally,
linking strategies were included to biofunctionalize the
nanomatrix with neurotrophic factors such as BDNF (12).
As outlined in the introduction, neurotrophic factors
are important to mediate survival and sprouting of audi-
tory neurons in vitro and in vivo. However, BDNF is not
an ideal molecule for clinical inner ear applications
because of its short in vivo half-life time. Small biomi-
metic compounds could offer an interesting way to solve
this problem. However, to our knowledge, only few
biomimetic analogues for BDNF have been published, reproduction of this article is prohibited.
NANOCI e227and their effects on the inner ear neurons are as yet
unknown (13). Partner EMC, therefore, set out to design
and produce small molecule biomimetic compounds
deduced from the different structural parts (loops) of
the BDNF molecule with high stability, biocompatibility,
and bioavailability in the inner ear. Promising candidates
were tested in an in vitro bioassay using an auditory
neuron explant assay. Results of this screen are currently
prepared for publication.
For stable locking of auditory neurites on the platinum
electrode surface and optimization of electrode con-
ductivity, different nanofunctionalizations were devel-
oped and tested by partner Bar-Ilan University (BIU).
From a pool of several candidates, hybrid nanocompo-
sites of conductive polymers and multiwall carbon nano-
tubes were found to substantially roughen the platinum
surface and thereby to improve conductivity of standard
cochlear implant platinum pads in electrochemical
measurements by partner MEDEL (14). In addition,
these nanocomposites substantially reduced stimulation
thresholds of auditory neuronal explant cultures on
multi-electrode arrays compared with standard grey
platinum surfaces.
WP2—Nanofunctionalization of the Electrode
Array Surface
This work package was designed to structurally opti-
mize the non-conductive silicone carrier surface of the CI
for drug delivery and to implement antibacterial activity.
Partner HES-SO evaluated two different technologies
for release of proteins from reservoirs on the surface.
Firstly, the solid on liquid (SOLID) nanotechnology was
evaluated. To this end, the silicone carrier of the elec-
trode was further coated with a parylene layer containing
microscale reservoirs with 60mm holes created by laser
(15,16). This allowed for release of fluorescent mol-
ecules (fluorescine), used as reporters in these studies.
In addition, nanostructurization methods such as local-
ized irradiations of Parylene-coated surfaces passed bio-
compatibility testing with an auditory neuron survival
assay, suggesting that such technologies might be used
for precise local etching of a parylene-coated surface to
create wells or nanopores for controlled release of growth
factors (17).
Finally, a simpler approach was evaluated, wherein
fluorescein crystals, in powder form, were encapsulated
in a thin layer of parylene, hence creating random nano-
meter-sized pinholes. This was found to be effective for
controlled drug-release from the electrode surface (18).
Therefore, the approach was selected, as it would facili-
tate the storage of proteins on the CI silicone surface in a
solid form (powder), greatly improving handling and
shipping properties.
To diminish the risk for infections and colonization of
the electrode array, partner BIU further modified the non-
conductive silicone parts with antimicrobial nanopar-
ticles. ZnO-MgF2 and CuZnO were incorporated into
the silicone array sonochemically. These nanoparticles
proved to be stably locked on the surface with minimal orCopyright © 2017 Otology & Neurotology, Inc. Unautabsent leaching of into artificial perilymph and with
substantial inhibition of biofilm formation (19).
WP3—Modeling, Coding, and Information Transfer
This work package addressed the functional exploita-
tion of the gapless electrode–auditory neuron interface
and looked into optimized design of future cochlear
implant systems with increased bi-directionality and
higher channel numbers.
Interface-dependent stimulation patterns were studied
using spiral ganglion neuron explant cultures on multi-
electrode arrays (MEAs) by the University of Bern (20).
We were able to demonstrate a reduction in the energy
needed to elicit a response as a function of the distance of
the stimulating electrode to the neuronal culture. This
proved the key hypothesis that the gapless interface
allows for reduction of stimulation energy.
In addition, optimization of stimulation pulses using
interphase gaps, trains of pulses, and long biphasic pulses
was assessed. The latter were also shown to allow for a
reduction of the energy needed for stimulation of SGNs
(20). The close proximity of the electrodes to the neurons
allows many electrodes to be active at the same time, thus
imposing less strict temporal restriction on coding strat-
egies compared with current CI systems. Based on this
data, sound coding strategies for an implant featuring a
gapless interface and more than 30 independent channels
were modeled using a custom-made, multicompartment
model of the auditory nerve by partner MEDEL (data not
published).
To increase bi-directionality of future CI-systems, a
Fabry–Perot fiber tip sensor was developed for measure-
ment of temperature and pressure suitable for incorpora-
tion into the electrode array. The system includes a
low-bending loss fiber equipped with a solid on liquid
deposited terminal (21). The sensitivity of the system
theoretically allows for the detection of contact of the tip
with the surrounding structures in the cochlea, interesting
for measuring insertion forces in robotic surgery, but also
potentially for use as an implantable microphone or
pressure sensor.
WP 4—Bioassays
A variety of bioassays were used in NANOCI to test
growth factors, growth factor mimetics, nanomaterials,
electrode surfaces, drug release, antibacterial activity,
and stimulation patterns, among other entities. The part-
ner University of Tu¨bingen tested the injectable, peptide-
based hydrogel developed by partner EMC for it’s
permissive properties to facilitate neurite growth towards
the CI in a spiral ganglion explant assay (12). In addition,
the partner University of Uppsala studied neural progen-
itor cell-derived spiral ganglion-like neurons (22). They
also studied the regenerative capacity of human surgery-
derived vestibular neurons (23) as well as the possibility
of attracting and guiding these primary vestibular
neurons in a 3-D nanomatrix (Li et al., Unpublished
data, currently under revision). In addition, histological
studies were undertaken to better understand the spiralhorized reproduction of this article is prohibited.
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FIG. 2. Prototype of the NANOCI electrode array featuring 36 electrodes on table (A) and after insertion into a cadaveric human temporal
bone, as visualized through cone-beam computed tomography (B andC). This prototype yields proof of concept, that channel numbers can
be tripled with today’s manufacturing methods. No intracochlear damage and an intact basilar membrane were observed (D). However, due
to increased stiffness of the device, a full insertion was not possible.
e228 P. SENN ET AL.ganglion anatomy and its relevance for cochlear implan-
tation today as well as for potential future systems with a
gapless interface to auditory neurons (24–26).
These results show, for the first time that the human
auditory nerve has a regenerative capacity and that
auditory neurons can grow through a 3-D nanomatrix.
The histopathological studies also reveal potential
underlying mechanisms that may allow human auditory
neurons to, unlike their animal counterparts, persist
after hair cell loss, making the use of cochlear implants
possible.
WP5—Imaging, Biocompatibility, and Release
Dynamics of the Modified CI Electrode
The aims of this work package were 1) to assess the
neurotrophin release from hydrogels and from implant
surfaces, 2) to measure and visualize the gap between the
electrode array and the medial cochlear wall using cone-
beam computed tomography (CBCT), and 3) to assess
the biocompatibility and safety of the modified electrode
array after coating with nanomaterials. The partner at
the University of Tampere, in collaboration with others,
mainly led this WP.
It was demonstrated that the release of neurotrophins
or small molecules in a phantom model with artificial
perilymph (data not published) corresponds to the in vivo
distribution of labeled Gadolinium nanocomposites of
TrkB-ligands in the rat cochlea after transtympanic
injection, as measured by MRI (27,28). Based on these
experiments, the inner ear distribution of neurotrophins
released from the hydrogel and from the cochlear implant
surface was predicted.
For the second aim, imaging parameters of cone-
beam CT were optimized yielding higher resolution atCopyright © 2017 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. 38, No. 8, 2017lower irradiation doses. Cadaveric human temporal
bones were implanted with different human grade coch-
lear implant electrode arrays (Fig. 2) and studied with
the optimized CBCT settings for insertion depth, scalar
location, and the distance of the array from the modiolar
wall (29).
Finally, the biocompatibility and toxicity of nanotech-
nologically modified electrode components were eval-
uated in vitro using the BALB/c3T3 and NR8383 cell
lines following the ISO 10993–5 and OECD GD-129
guidelines. No in vivo or specific ototoxicity tests were
performed for the bulk of nanomaterial candidates and
toxicity was predicted based on tissue equivalents at this
stage. Some of the earlier candidates for antibacterial
nanocoating in the project (ZnO and MgF2) were later
abandoned due to toxicity in these assays. The nano-
composites used to coat the platinum electrode parts
(multiwall carbon nanotubes) were found to be not toxic
to BALB/c3T3 cells, while slightly decreasing viability
of NR8383 cells (30).
WP6—Pilot, Animal Grade nanoCI
Multicomponent Validation
The final goal of work package 6 was to develop an
animal-grade prototype for in vivo testing incorporating the
different nano- and bio-functionalization discussed above.
The partner MEDEL produced a 4-channel guinea
pig electrode array (Fig. 3), which was then functionalized
with different components. Namely 1) conductive
polyTh copolymer (pEDOT)/oxidized multiwall carbon
nanotubes bound on platinum contacts, 2) parylene-coated
electrode array carrier doped with antifouling agent
(CuZnO nanoparticles), and 3) 7,8,3-trihydroxyflavone,
a BDNF analogue shown to act as a high affinity agonist reproduction of this article is prohibited.
FIG. 3. Specifications (A) and photographs of the prototype on table (B) and inserted into the cochlea (C) of the guinea pig cochlear implant
with four electrodes (arrows in B). The length of the intracochlear array is 4mm, as indicated with a stopper (blue oval) located between two
dark markers at distance 3 and 5mm from the tip for better estimate of achieved insertion depth. Catheters for intracochlear injection of the
nanomatrix in fluidic form (D). The catheters were manufactured in two variants with different diameters of the silicone tubing (0.3mm with
yellow standard syringe needle and 0.6mm with white standard syringe needle). The black dot indicates the 3-mm insertion depth as a
reference point (arrows in D). CI indicates cochlear implants.
NANOCI e229for the TrkB receptor, deposited in solid state in the surface
of the electrode array carrier.
Furthermore, MEDEL produced a catheter for intra-
cochlear application of the purified and laminin-loaded
hydrogel (produced by EMC under WP2, Fig. 3D).Copyright © 2017 Otology & Neurotology, Inc. Unaut
FIG. 4. Proof of concept of the gapless interface between auditory neu
deafened guinea pig inner ear in vivo (B). Auditory neurons are stainedwi
are stained in blue (DAPI nuclear staining), photograph provided by MarcThe multicomponent validation of these products
included first the typical quality and performance testing
at MEDEL, followed by in vivo experiments performed
at the University of Tu¨bingen using a deafened guinea pig
animal model. Deafened guinea pigs were implantedhorized reproduction of this article is prohibited.
rons (green) and the CI-electrode array in scheme (A) and in the
th a neuron-specific marker for b-III tubulin (green, TUJ), cell nuclei
us Mu¨ller and Hubert Lo¨wenheim. CI indicates cochlear implants.
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Withlow, Renate Spohn, Raphael Kiran, Roland Hessler,
e230 P. SENN ET AL.with standard and modified guinea pig cochlear implant
electrode arrays (Fig. 3) in combination with function-
alized nanomatrix gels applied through the aforemen-
tioned catheter (Fig. 3D). The in vivo experiments
yielded proof of principle that neurites can grow under
neurotrophin stimulation and through structural support
from the nanomatrix into the scala tympani and onto the
surface of the electrode array, forming a gapless interface
in the deafened and implanted cochlea (Fig. 4). Func-
tionally, the gapless interface led to lower stimulation
thresholds and a larger dynamic range in these animals in
vivo and the detailed results are currently being prepared
for publication.
Finally, MEDEL tested the limits of today’s manu-
facturing technologies and built a human-grade prototype
electrode array featuring 36 platinum contacts (Fig. 2A).
The human-grade prototype electrode array was inserted
into a cadaveric human temporal bone at the University
of Tampere for imaging (and not used in vivo) (Fig. 2B).
No intracochlear damage was observed (Fig. 2B and C),
however due to increased stiffness related to the higher
platinum contents of the array, it could not be fully
inserted into the cochlea.
DISCUSSION AND CONCLUSION
In conclusion, the NANOCI project yielded proof of
concept that a gapless interface between auditory neurons
and cochlear implant electrode arrays is feasible in vivo.
Functionally, the gapless interface led to lower stimu-
lation thresholds and a larger dynamic range in vivo
compared with untreated animals and to an up to fivefold
reduction in required stimulation energy in an in vitro
model using auditory neurons cultured on multi-elec-
trode arrays. The relevance of this promising observation
for potential future clinical applications remains
unknown at this point in time. Particularly, it cannot
be foreseen, how many regrown neurites will be func-
tionally relevant and how many parallel channels of the
cochlear implant can be effectively used for stimulation
in the future. In addition, the total energy consumption of
a future CI system that could be based on the NANOCI
principle cannot be predicted based on our experiments,
as many factors relevant to clinical CI systems were not
taken into account in the experimental models. Several
other issues such as safety and functional stability over
time and beyond re-implantation procedures need to be
seriously addressed. Nevertheless, we remain optimistic
that some of the developments made during the NANOCI
project may help to improve cochlear implant systems in
the future in one way or another. It is important to note
that all of the researchers experienced a substantial
benefit from the interdisciplinary collaboration of the
consortium partners involved in the project.
Acknowledgments: The authors would like to thank the fol-
lowing NANOCI collaborators for their valuable contri-
butions: Emanuele Marconi, Anne Tscherter, Ju¨rg Streit,
Hans Ruedi Widmer, Stefano di Santo, Marija Bostro¨m,
Sebastien Brun, Francois Feuvrier, Thierry Allen, HarryCopyright © 2017 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. 38, No. 8, 2017Frederik Klauser, Jochen Tillein, Giulia Mattini, So¨ren Schilp,
Teresa Melchionna, Raimund Naschberger, Ingeborg Hochmair
and Kirsten Leufgen. Further, they would like to thank Stefan
Heller and Daniel Bodmer for being part of the advisory board
and Silke Krol (project technical assistant) and Heico Frima
(project officer) for their valuable work for the project at the EU.
They would also like to thank Michal Natan for her contributions
to this work.REFERENCES
1. Shannon RF, Fu QJ, Galvin J 3rd. The number of spectral channels
required for speech recognition depends on the difficulty of the
listening situation. Acta Otolaryngol Suppl 2004;50–4.
2. Friesen LS, Shannon RV, Baskent D, Wang X. Speech recognition
in noise as a function of the number of spectral channels: com-
parison of acoustic hearing and cochlear implants. J Acoust Soc Am
2001;110:1150–63.
3. Wilson BS, Dorman MF. Cochlear implants: current designs and
future possibilities. J Rehab Res Dev 2008;45:695–730.
4. Fritzsch B, Tessarollo L, Coppola E, Reichardt LF. Neurotrophins
in the ear: their roles in sensory neuron survival and fiber guidance.
Prog Brain Res 2004;146:265–78.
5. Shibata SB, Cortez SR, Beyer LA, et al. Transgenic BDNF induces
nerve fiber regrowth into the auditory epithelium in deaf cochleae.
Exp Neurol 2010;223:464–72.
6. Glueckert R, Bitsche M, Miller JM, et al. Deafferentation-associ-
ated changes in afferent and efferent processes in the guinea pig
cochlea and afferent regeneration with chronic intrascalar brain-
derived neurotrophic factor and acidic fibroblast growth factor.
J Comp Neurol 2008;507:1602–21.
7. Shepherd RK, Coco A, Epp SB, Crook JM. Chronic depolarization
enhances the trophic effects of brain-derived neurotrophic factor in
rescuing auditory neurons following a sensorineural hearing loss.
J Comp Neurol 2005;486:145–58.
8. Landry TG, Fallon JB, Wise AK, Shepherd RK. Chronic neuro-
trophin delivery promotes ectopic neurite growth from the spiral
ganglion of deafened cochleae without compromising the spatial
selectivity of cochlear implants. J Comp Neurol 2013;521:
2818–32.
9. Liu W, Kinnefors A, Bostrom M, Rask-Andersen H. Expression of
TrkB and BDNF in human cochlea-an immunohistochemical study.
Cell Tissue Res 2011;345:213–21.
10. Liu W, Glueckert R, Kinnefors A, Schrott-Fischer A, Bitsche M,
Rask-Andersen H. Distribution of P75 neurotrophin receptor in
adult human cochlea–an immunohistochemical study. Cell Tissue
Res 2012;348:407–15.
11. McGrath AM, Novikova LN, Novikov LN, Wiberg M. BD Pur-
aMatrix peptide hydrogel seeded with Schwann cells for peripheral
nerve regeneration. Brain Res Bull 2010;83:207–13.
12. Frick C, Muller M, Wank U, et al. Biofunctionalized peptide-based
hydrogels provide permissive scaffolds to attract neurite outgrowth
from spiral ganglion neurons. Colloids Surf B Biointerfaces
2016;149:105–14.
13. Massa SM, Yang T, Xie Y, et al. Small molecule BDNF mimetics
activate TrkB signaling and prevent neuronal degeneration in
rodents. J Clin Invest 2010;120:1774–85.
14. Ostrovsky S, Hahnewald S, Kiran R, et al. Conductive hybrid
carbon nanotube (CNT)-polythiophene coatings for innovative
auditory neuron-multi-electrode array interfacing. RCS Adv 2016;
6:41714–23.
15. Charmet J, Banakh O, Laux E, et al. Solid on liquid deposition. Thin
Solid Films 2010;518:5061–5.
16. Homsy A, Laux E, Jeandupeux L, et al. Solid on liquid deposition, a
review of technological solutions. Microelectron Eng 2015;141:
267–79.
17. Whitlow H, Norarat R, Roccio M, et al. MeV ion beam lithography
of biocompatible halogenated Parylenes using aperture masks. Nucl
Instrum Methods Phys Res B 2015;354:34–6. reproduction of this article is prohibited.
18. Homsy A, Laux E, Brossard J, et al. Fine control of drug delivery for 25. Liu W, Glueckert R, Linthicum FH, et al. Possible role of gap
NANOCI e231cochlear implant applications. Hear Balance Commun 2015;13:
153–9.
19. Natan M, Edin F, Perkas N, et al. Two are better than one:
Combining ZnO and MgF2 nanoparticles reduces Streptococcus
pneumoniae and Staphylococcus aureus biofilm formation on
cochlear implants. Adv Funct Mater 2016;26:2473–81.
20. Hahnewald S, Marconi E, Streit J, et al. Response profiles of murine
spiral ganglion neurons on multi-electrode arrays. J Neural Eng
2015;13:016011.
21. Llera M, Aellen T, Hervas J, et al. Liquid-air based Fabry-Perot
cavity on fiber tip sensor. Optics Express 2016;24:1–12.
22. Edin F, Liu W, Bostrom M, Magnusson PU, Rask-Andersen H.
Differentiation of human neural progenitor cell-derived spiral
ganglion-like neurons: a time-lapse video study. Acta Otolaryngol
2014;134:441–7.
23. Edin F, Liu W, Li H, Atturo F, Magnusson PU, Rask-Andersen H.
3-D gel culture and time-lapse video microscopy of the human
vestibular nerve. Acta Otolaryngol 2014;134:1211–8.
24. Liu W, Edin F, Atturo F, et al. The pre- and post-somatic segments
of the human type I spiral ganglion neurons—structural and func-
tional considerations related to cochlear implantation.Neuroscience
2015;284:470–82.Copyright © 2017 Otology & Neurotology, Inc. Unautjunction intercellular channels and connexin 43 in satellite glial
cells (SGCs) for preservation of human spiral ganglion neurons: A
comparative study with clinical implications. Cell Tissue Res
2014;355:267–78.
26. Rask-Andersen H, Liu W. Auditory nerve preservation and regen-
eration in man: relevance for cochlear implantation. Neural Regen
Res 2015;10:710–2.
27. Pyykko I, Zou J, Schrott-Fischer A, Glueckert R, Kinnunen P. An
overview of nanoparticle based delivery for treatment of inner ear
disorders. Methods Mol Biol 2016;1427:363–415.
28. Zou J, Ostrovsky S, Israel L, Lellouche J, Pyykko¨ I. Targeted
delivery of contrast agents to the tympanic medial wall at minimum
amount and the efficient uptake in the inner ear through oval and
round windows. Austin J Radiol 2015;2:1034.
29. Zou J, Hannula M, Lehto K, et al. X-ray microtomographic
confirmation of the reliability of CBCT in identifying the scalar
location of cochlear implant electrode after round window insertion.
Hear Res 2015;326:59–65.
30. Mannerstrom M, Zou J, Toimela T, Pyykko I, Heinonen T. The appli-
cability of conventional cytotoxicity assays to predict safety/toxicity of
mesoporous silica nanoparticles, silver and gold nanoparticles and
multi-walled carbon nanotubes. Toxicol In Vitro 2016;37:113–20.horized reproduction of this article is prohibited.
Otology & Neurotology, Vol. 38, No. 8, 2017
